Melanoma and eruptive naevi during cetuximab treatment: epidermal growth factor inhibitors and a common concern
| Autor: | Emi Dika, F. Tartari, Martina Lambertini, T. Ferrari |
|---|---|
| Přispěvatelé: | Ferrari T., Lambertini M., Tartari F., Dika E. |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Oncology
medicine.medical_specialty Cetuximab business.industry Colorectal cancer Melanoma MEDLINE Dermatology medicine.disease 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine business neoplasms Medical therapy medicine.drug EGFR inhibitors |
| Popis: | A 59-year-old patient was referred to the Melanoma Unit for a dermatologic consultation due to the eruptive onset of multiple hyperpigmented nevi one-month after the beginning of their medical therapy with cetuximab for metastatic colorectal cancer. No other side-effects were reported, with the exception of a mild cutaneous xerosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|